Editorial: (New drug (LCZ696) for the treatment of heart failure with reduced ejection fraction after 10 years. Can one study change the guidelines?).
| Title | Editorial: (New drug (LCZ696) for the treatment of heart failure with reduced ejection fraction after 10 years. Can one study change the guidelines?). |
| Publication Type | Journal Article |
| Year of Publication | 2014 |
| Authors | Athyros, V. G., Katsiki N., & Karagiannis A. |
| Journal | Curr Vasc Pharmacol |
| Volume | 12 |
| Issue | 6 |
| Pagination | 867-9 |
| Date Published | 2014 |
| ISSN | 1875-6212 |
| Keywords | Aminobutyrates, Angiotensin Receptor Antagonists, Heart Failure, Humans, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Stroke Volume, Tetrazoles, Time Factors, Treatment Outcome |
| Alternate Journal | Curr Vasc Pharmacol |
| PubMed ID | 25516014 |
